ENVERIC BIOSCIENCES Trademark

Trademark Overview

On Friday, November 13, 2020, a trademark application was filed for ENVERIC BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the ENVERIC BIOSCIENCES trademark a serial number of 90318633. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Jay Pharma, Inc.. The ENVERIC BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Pharmaceutical products for the treatment of cancer
enveric biosciences

General Information

Serial Number90318633
Word MarkENVERIC BIOSCIENCES
Filing DateFriday, November 13, 2020
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7019550
Registration DateTuesday, April 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesAnti-cancer preparations; Pharmaceutical products for the treatment of cancer
Disclaimer with Predetermined Text"BIOSCIENCES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2021
Primary Code005
First Use Anywhere DateThursday, November 17, 2022
First Use In Commerce DateThursday, November 17, 2022

Trademark Owner History

Party NameJay Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNaples, FL 34103
Party NameJay Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaples, FL 34103
Party NameJay Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaples, FL 34103

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 2, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 18, 2023USE AMENDMENT FILED
Monday, February 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 18, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2022SOU EXTENSION 2 GRANTED
Monday, July 25, 2022SOU EXTENSION 2 FILED
Monday, July 25, 2022TEAS EXTENSION RECEIVED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, January 12, 2022SOU EXTENSION 1 FILED
Wednesday, January 12, 2022TEAS EXTENSION RECEIVED
Wednesday, October 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 26, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 26, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 26, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 26, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, April 22, 2021ASSIGNED TO EXAMINER
Wednesday, January 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 17, 2020NEW APPLICATION ENTERED

Related Keywords

biosciences enveric cancer treatment products preparations anti pharmaceutical